Search

Background: Syndrome of inappropriate antidiuretic(SIAD) occurs secondary to various diseases, which is characterised by hypotonic hyponatremia and impaired urinary diluting capacity. Research on SIAD in both domestic and international contexts has a long history. This study objectively and comprehensively analyses the research trends, hotspots and development of SIAD research of the past 20 years using the method of bibliometric analysis. Methods: The 2003-2022 data in the Web of Science Core Collection database were searched. The Bibliometrix software package, VOSviewer and CiteSpace were used to mine, extract and visualise the retrieved literature, and the generated maps were used in analysing the main topics and trends in the field of SIAD research. Results: A total of 1215 articles published in 623 journals were included in the analysis, with a total of 18,886 citations. Results showed that the research output on SIAD has continuously increased in the past 20 years, and the United States had the highest number of publications and citations. Keywords with the highest burst strength in recent years were the most mentioned keywords, in addition to the search terms 'hyponatremia', 'covid-19', and 'mortality'. Thus, the relationship among SIAD, covid-19 and mortality may become research frontiers and trends. Fifteen milestone articles were identified through co-citation analysis, which mainly focused on the pathophysiology and treatment of SIAD. Conclusion: Based on bibliometric analysis and knowledge mapping, this study summarises development trends in the field of SIAD research, providing references for current and future research into SIAD. [ABSTRACT FROM AUTHOR]

A Chinese family was identified to have two patients with rickets, an adult female and a male child (proband), both exhibiting signs related to X-linked hypophosphatemic rickets (XLH). Gene sequencing analysis revealed a deletion of adenine at position 1985 (c.1985delA) in the PHEX-encoding gene. To investigate the relationship between this mutation and the pathogenicity of XLH, as well as analyze the effects of different dosages of PHEX gene mutations on clinical phenotypes, we developed a rat model carrying the PHEX deletion mutation. The CRISPR/Cas9 gene editing technology was employed to construct the rat model with the PHEX gene mutation (c.1985delA). Through reproductive procedures, five genotypes of rats were obtained: female wild type (X/X), female heterozygous (-/X), female homozygous wild type (-/-), male wild type (X/Y), and male hemizygous (-/Y). The rats with different genotypes underwent analysis of growth, serum biochemical parameters, and bone microstructure. The results demonstrated the successful generation of a stable ratmodel inheriting the PHEX gene mutation. Compared to thewild-type rats, the mutant rats displayed delayed growth, shorter femurs, and significantly reduced bone mass. Among the female rats, the homozygous individuals exhibited the smallest body size, decreased bone mass, shortest femur length, and severe deformities. Moreover, the mutant rats showed significantly lower blood phosphorus concentration, elevated levels of FGF23 and alkaline phosphatase, and increased expression of phosphorus regulators. In conclusion, the XLH rat model with the PHEX gene mutation dosage demonstrated its impact on growth and development, serum biochemical parameters, and femoral morphology. [ABSTRACT FROM AUTHOR]

Neoadjuvant chemotherapy (NAC) for breast cancer is widely used in the clinical setting to improve the chance of surgery, breast conservation and quality of life for patients with advanced breast cancer. A more accurate efficacy evaluation system is important for the decision of surgery timing and chemotherapy regimen implementation. However, current methods, encompassing imaging techniques such as ultrasound and MRI, along with non-imaging approaches like pathological evaluations, often fall short in accurately depicting the therapeutic effects of NAC. Imaging techniques are subjective and only reflect macroscopic morphological changes, while pathological evaluation is the gold standard for efficacy assessment but has the disadvantage of delayed results. In an effort to identify assessment methods that align more closely with real-world clinical demands, this paper provides an in-depth exploration of the principles and clinical applications of various assessment approaches in the neoadjuvant chemotherapy process. [ABSTRACT FROM AUTHOR]

Background: Various neurologic manifestations have been reported in patients with COVID-19, mostly in retrospective studies of patients admitted to hospital, but there are few data on patients with mild COVID-19. We examined the frequency and persistence of neurologic/neuropsychiatric symptoms in patients with mild COVID-19 in a 1-year prospective cohort study, as well as assessment of use of health care services and patient-reported outcomes. Methods: Participants in the Alberta HOPE COVID-19 trial (hydroxychloroquine v. placebo for 5 d), managed as outpatients, were pro- spectively assessed 3 months and 1 year after their positive test result. They completed detailed neurologic/neuropsychiatric symptom questionnaires, the telephone version of the Montreal Cognitive Assessment (T-MoCA), the Kessler Psychological Distress Scale (K10) and the EuroQol EQ-5D-3L (measure of quality of life). Close informants completed the Mild Behavioural Impairment Checklist (MBI-C) and the Informant Questionnaire on Cognitive Decline in the Elderly. We also tracked use of health care services and neurologic investigations. Results: The cohort consisted of 198 participants (87 female [43.9%] median age 45 yr, interquartile range 37--54 yr). Of the 179 par- ticipants with symptom assessments, 139 (77.6%) reported at least 1 neurologic symptom, the most common being anosmia/dysgeusia (99 [55.3%]), myalgia (76 [42.5%]) and headache (75 [41.9%]). Forty patients (22.3%) reported persistent symptoms at 1 year, includ- ing confusion (20 [50.0%]), headache (21 [52.5%]), insomnia (16 [40.0%]) and depression (14 [35.0%]); 27/179 (15.1%) reported no improvement. Body mass index (BMI), a history of asthma and lack of full-time employment were associated with the presence and persistence of neurologic/neuropsychiatric symptoms; female sex was independently associated with both (presence: odds ratio [OR] adjusted for age, race, BMI, history of asthma and neuropsychiatric history 5.04, 95% confidence interval [CI] 1.58 to 16.10). Compared to participants without persistent symptoms, those with persistent symptoms had more hospital admissions and family physician visits, and worse MBI-C scores and less frequent independence for instrumental activities at 1 year (83.8% v. 97.8%, p = 0.005). Patients with any or persistent neurologic symptoms had worse psychologic distress (K10 score ≥ 20: adjusted OR 12.1, 95% CI 1.4 to 97.2) and quality of life (median EQ-5D-3L visual analogue scale rating 75 v. 90, p < 0.001); 42/84 (50.0%) had a T-MoCA score less than 18 at 3 months, as did 36 (42.9%) at 1 year. Participants who reported memory loss were more likely than those who did not report such symptoms to have informant-reported cognitive-behavioural decline (1-yr MBI-C score ≥ 6.5: adjusted OR 15.0, 95% CI 2.42 to 92.60). Interpretation: Neurologic/neuropsychiatric symptoms were commonly reported in survivors of mild COVID-19, and they persisted in 1 in 5 patients 1 year later. Symptoms were associated with worse participant- and informant-reported outcomes. Trial registration: ClinicalTrials.gov, no. NCT04329611 [ABSTRACT FROM AUTHOR]

Internet of Things (IoT) technology is accelerating societal and lifestyle changes, yet its application in E-government public services remains inadequate. E-government public services have a direct impact on public life and development, and they reflect the government's governance capabilities. Technological improvement is critical to the development of E-government public services. In this paper, the technical characteristics and advantages of IoT technology applied to E-government public services are systematically outlined and analyzed. The technical challenges faced by the current development of E-government public services are examined, and how IoT technology can be leveraged to improve these services is explored. By integrating emerging technology applications, creating a data-driven environment and a distributed multicenter, opening up government-civilian interaction channels, and developing intelligent scene-based services, IoT is utilized to significantly enhance public service experiences and effectively improve public services. The utilization of IoT technology in E-government public services presents enormous potential, as it facilitates the advancement of such services and supports the transformation of governmental organizations and social governance models. This report offers guidance for policy makers, implementers, and IoT technology engineers on comprehending the implications of IoT technology in E-government public services. [ABSTRACT FROM AUTHOR]

The effect of mold temperature on microstructure and mechanical properties of a rheo-squeeze casting (RSC) Mg--3Nd--0.2Zn--0.4Zr (NZ30K) alloy were investigated. The results indicated that the rise of mold temperature contributed to the increase of particle size and alloy density and the decrease of dislocation density. The rapid coarsening and then the normal growth of the particles during solution treatment were observed, and the long-rod-like Zn2Zr3 phase occurred. After age treatment, rod-like b9 precipitate was found in the conventional squeeze casting (CSC) alloy, while two types of precipitates including b9 phase and small plate-like b0 phase were observed in the RSC alloy. The amount of Zn2Zr3 phase was increased with rising mold temperature. Compared with the T6-treated CSC sample, the T6-treated RSC sample presented higher mechanical properties due to the larger precipitation strengthening contribution, and the yield strength, ultimate tensile strength, and elongation were up to 160 MPa, 296 MPa, and 7.7%. [ABSTRACT FROM AUTHOR]

Mg–3.0Y–2.5Nd–1.0Gd–xZn–0.5Zr (x 5 0, 0.2, 0.5, and 1.0) (wt%) alloys were produced by metallic and sand mold casting to study the microstructure and mechanical properties of the alloys. The as-cast Zn-free alloys consist of a-Mg and eutectics, whereas the Zn-containing alloys contain additional long-period stacking ordered (LPSO) structures. With a higher solidification, the cooling rate brought by metallic mold casting, grains, and eutectics are refined, which enhances the elongation of the alloys, accompanied by a decrease of area fraction of the LPSO structure. Some residual eutectics in the Mg–3.0Y–2.5Nd–1.0Gd–1.0Zn–0.5Zr alloys act as obstacles to grain boundary migration during solution treatment, which make the average grain size 15–20 lm smaller than that of the other alloys and hence improve the elongation of the alloys. The Zn addition brings notable enhancements to mechanical properties of the alloys due to solid solution strengthening of Zn. Especially, the peak-aged Mg–3.0Y–2.5Nd–1.0Gd–0.5Zn–0.5Zr alloys perform with the highest overall tensile properties. [ABSTRACT FROM AUTHOR]